Category: Prescription Drugs
Global Prescription Drugs
-
Peripheral Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2030
... center markets. The global peripheral neuropathy market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are surge in geriatric and obese population and increasing ... Read More
-
Sarcopenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global sarcopenia treatment market has witnessed a substantial surge in recent years, thanks to a growing aging population and a heightened interest in preventive healthcare. The market has seen a significant rise in the sale ... Read More
-
Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent Developments - Forecast to 2030
... Million in 2023, and is projected to reach US$ 6,138 Million by 2030. Narcolepsy is a chronic neurological disorder that affects the brain’s ability to regulate sleep-wake cycles, resulting in excessive daytime sleepiness (EDS) and, ... Read More
-
Global Optic Neuritis Treatment Market - 2023-2030
... during the forecast period 2023-2030. Optic neuritis (ON) is a condition in which the optic nerve, the nerve that supplies the eye, swells up or becomes irritated. Optic neuritis typically gets better by itself. Steroid ... Read More
-
Global Cocaine Intoxication Drugs Market - 2023-2030
... during the forecast period 2023-2030. Cocaine intoxication is a condition in the person not only high from using the drug but also have body-wide symptoms that can make the person ill and impaired. Cocaine intoxication ... Read More
-
Schizophrenia Therapeutics Market by Therapeutic Class (Second Generation, Third Generation), Administration (Injectable, Oral), Distribution Channel - Global Forecast 2024-2030
... reach USD 8.08 billion in 2024, at a CAGR 4.94% to reach USD 11.06 billion by 2030. Global Schizophrenia Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Schizophrenia Therapeutics ... Read More
-
Animal Sedative Market by Type (Alpha-2 Agonists, Barbiturates, Benzodiazepines), Animal Type (Companion Animals, Equine, Livestock), Route of Administration, End-Use - Global Forecast 2024-2030
... 2023 and expected to reach USD 91.02 million in 2024, at a CAGR 13.50% to reach USD 195.28 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Animal Sedative ... Read More
-
Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... USD 255.63 million in 2023 and expected to reach USD 277.28 million in 2024, at a CAGR 8.56% to reach USD 454.31 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Statins Market by Type (Natural Statins, Synthetic Statins), Drug Class (Atorvastatin, Fluvastatin, Lovastatin), Application, End-User - Global Forecast 2024-2030
... USD 33.30 billion in 2024, at a CAGR 5.85% to reach USD 47.08 billion by 2030. Global Statins Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Statins Market. It offers ... Read More
-
Equine Pharmaceuticals & Supplements Market by Product (Pharmaceutical, Supplement), Distribution Channel (Drug Stores, Veterinary Hospitals) - Global Forecast 2024-2030
... expected to reach USD 983.49 million in 2024, at a CAGR 5.78% to reach USD 1,379.52 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Equine Pharmaceuticals & Supplements ... Read More
-
Obesity Treatment Market by Drugs (Appetite Suppressants, Combination Drugs, Malabsorption & Satiety Drugs), Surgery & Devices (Adjustable Gastric Banding, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures) - Global Forecast 2024-2030
... was estimated at USD 17.14 billion in 2023 and expected to reach USD 18.88 billion in 2024, at a CAGR 10.24% to reach USD 33.93 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Sexual & Reproductive Health Drugs Market by Drugs Type (Erectile Dysfunction Drugs, Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Global Forecast 2024-2030
... Reproductive Health Drugs Market size was estimated at USD 31.64 billion in 2023 and expected to reach USD 35.83 billion in 2024, at a CAGR 13.34% to reach USD 76.03 billion by 2030. Global Sexual ... Read More
-
Analgesics Market by Drug Type (Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, Salicylates), Type (Non-Opioids, Opioids), Route of Administration, Distribution - Global Forecast 2024-2030
... to reach USD 23.75 billion in 2024, at a CAGR 8.79% to reach USD 39.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Analgesics Market. It offers a ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Pleurodynia Treatment Market by Diagnosis (Blood Test, Culture Test, X-ray), Treatment (Analgesics, Immunoglobulin), Mode Of Administration, End-User - Global Forecast 2024-2030
... expected to reach USD 145.40 million in 2024, at a CAGR 5.66% to reach USD 203.54 million by 2030. Global Pleurodynia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Vulvodynia Treatment Market by Type (Biofeedback & Physical Therapy, Intralesional Injections, Oral Treatment), Indication (Generalized Vulvodynia, Localized Vulvodynia), Providers - Global Forecast 2024-2030
... 2023 and expected to reach USD 60.82 billion in 2024, at a CAGR 9.62% to reach USD 105.67 billion by 2030. Global Vulvodynia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Diuretics Drugs Market by Drug Type (Calcium Sparing Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics), Distribution Channel (Drug Stores, Hospital Pharmacies, Online Pharmacies), Route of Administration, Applications - Global Forecast 2024-2030
... was estimated at USD 1.19 billion in 2023 and expected to reach USD 1.29 billion in 2024, at a CAGR 8.54% to reach USD 2.12 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Muscle Relaxants Drug Market by Drug (Facial Muscle Relaxant, Neuromuscular Relaxant, Skeletal Muscle Relaxant), Distribution (Clinics, Drug Stores, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.78 billion in 2024, at a CAGR 7.88% to reach USD 7.55 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Muscle ... Read More
-
Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Global Forecast 2024-2030
... expected to reach USD 1,026.86 million in 2024, at a CAGR 8.74% to reach USD 1,705.58 million by 2030. Global Postpartum Depression Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Global Forecast 2024-2030
... and expected to reach USD 1.08 billion in 2024, at a CAGR 6.49% to reach USD 1.58 billion by 2030. Emergency contraceptive pills, commonly called the “morning-after pill,” are a type of birth control method ... Read More
-
Cold Pain Therapy Market by Product (OTC Products, Prescription Products), Distribution Channel (E-commerce, Hospital Pharmacy, Retail Pharmacy), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.22 billion in 2024, at a CAGR 8.20% to reach USD 3.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cold Pain ... Read More
-
Anti-Obesity Drugs Market by Drug Type (Over-The-Counter Drugs, Prescription Drugs), Mechanism of Action (Centrally Acting Drugs, Peripherally Acting Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 4.09 billion in 2024, at a CAGR 6.86% to reach USD 6.10 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Drugs ... Read More
-
Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 46.99 billion in 2024, at a CAGR 8.97% to reach USD 78.90 billion by 2030. Global Women's Health MarketThe women's health market includes diagnosis, treatments, medications, surgical procedures, and ... Read More
-
Anti-obesity Prescription Drugs Market by Drug Class (Bupropion & Naltrexone, Liraglutide, Lorcaserin), Age Group (Adult, Pediatric), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 6.71 billion in 2024, at a CAGR 8.12% to reach USD 10.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-obesity Prescription ... Read More
-
Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), End-use (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2024-2030
... reach USD 10.81 billion in 2024, at a CAGR 8.44% to reach USD 17.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Therapeutics Market. It offers a ... Read More
Research Assistance
